Table of Contents

TABLE OF CONTENTS 1-3 ATOS PHARMA 4-5 1. ONCOLOGY 1.1. Viscum Fraxini 2 2. CARDIOVASCULAR 2.1. Cardioton 8-9 2.2. Statosan 10-11 3. GASTRO-INTESTINAL 3.1. Carmipret 12-13 3.2. Chamopect 14-15 3.3. Heparex 16-17 4. GYNAECOLOGY 4.1. Fiminosan 18-19 4.2. Femicur 20-21 4.3. Femivit 22-23 5. HEPATO-BILIARY 5.1. Heparsan 24-25 6-7

TABLE OF CONtENtS

Table of Contents
6. IMMUNOLOGY 6.1. Immulone 26-27 6.2. Mulone 28-29 6.3. Viscum Fraxini 4 7. NEUROPSYCHIATRY 7.1. Kingosan 32-33 7.2. Neuropatex 34-35 7.3. Safamood 36-37 7.4. Safamood Forte 38-39 7.5. Sedaneurin 40-41 8. RESPIRATORY 8.1. Rosinol 42-43 8.2. Thymotal 44-45 8.3. Thymotal Plus 46-47 9. RHEUMATOLOGY/ORTHOPEDIC 9.1. Boswelia 48-49 9.2. Herpago 50-51 9.3. Spondex 52-53 ALphABEtiCAL INdEX 64-65 30-31 11. MINERALS 11.1. Bio-Mag 58-59 11.2. BioZinc 60-61 11.3. Ritchkal 62-63 10. GENITO-URINARY 10.1. Cystinol 54-55 10.2. Prostasan 56-57

TABLE OF CONtENtS

TABLE OF CONtENtS

ATOS is a pioneer Phyto-Pharmaceutical company in Egypt which adopts the concept of natural healing by enhancing the bodys own healing forces using natural remedies from herbal extracts, dietary supplements and orthomolecular medicine. In the process of all illnesses there are energetic and biochemical imbalances either in the form of deficiencies of vital substances or accumulation of harmful metabolites, which in turn disrupt the health state of the human being. ATOS products are basically aiming to heal the whole person rather than just suppressing the symptoms of diseases, in accordance with this principle ATOS is manufacturing its whole range of products to offer a more comprehensive natural method of treatment for a variety of diseases through regaining the balance of the human being as a whole. This holistic approach is the keystone of the new uprising revolution in the field of medicine. In response to WHO declarations, ATOS Pharma was the first in Egypt

to support the concept of Holistic and Integrative Medicine that combines the benefits from conventional medicine as well as, well documented Complementary and Alternative Medicine (CAM) according to the regulations of World Health Organization on CAM. In coop eration with European Universities and international scientific centers ATOS has conducted researches in the field of natural remedies as a part of holistic medicine therapies. The products are developed to cover different fields: cancer management, cardiovascular, gastrointestinal, gynecology, hepato-biliary, immunology, neuropsychiatry, respiratory, genitourinary mineral and vitamin supplements. In order to ensure the highest quality of all products from ATOS, stringent criteria are applied during the selection of raw materials and only organic grown herbs, plants and natural ingredients are used. The outstanding efficacy, tolerability and therapeutic effects of the tablets,

capsules, liquid mixtures and drops are maintained by strict adherence to a comprehensive set of guidelines and rigorous quality control. To ensure the highest quality of all products from ATOS Pharma, we adhere to: Stringent criteria which are applied during the selection of raw materials with the use of organic grown herbs, plants and natural ingredients. The outstanding efficacy, tolerability, and therapeutic effects of the products which are maintained by strict adherence to a comprehensive set of guidelines and rigorous quality controls as well as the implementation of good laboratory practices (GLP) and good manufacturing practices (GMP). The production process which complies with national and international regulations that conform ISO 9001 standards. ATOS also complies with ISO 17025, ISO 14000, OHSAS 18001 and Demeter.

AtOS PhArmA

AtOS PhArmA

Viscum Fraxini 2
Immunomodulator/cytotoxic PROPERTIES AND ACTIONS: Viscum Fraxini 2, mistletoe extract, stimulates the T and B-cell components of the immune system, which leads to the expression and release of cytokines, proliferation and activation of immunocompetent cells; especially natural killer cells, T-cytotoxic cells and lymphokine activated killer cells. Treatment with Viscum Fraxini 2 is associated with an improvement of the quality of life of cancer patients. Viscum Fraxini 2 stimulates the secretion of endogenous -endorphins which leads to the control of pain. Viscum Fraxini 2 contains lectins which enhance apoptosis and viscotoxins which exert direct cytotoxic effect on tumor cells. INDICATIONS: Pleurodesis in malignant pleural effusion. Supportive for inoperable hepatocellular carcinoma patients. Complementary in breast cancer. DOSAGE: Dose in malignant pleural effusion: 5 ampoules of Viscum Fraxini 2 mixed with 10 ml of glucose 5% intrapleural weekly till complete pleurodesis or up to six weeks. Dose in inoperable hepatocellular carcinoma: Two ampoules subcutaneous per week are given till maximum response and/ or 3 ampoules intralesional (sonar guided) weekly for 6 weeks, course can be repeated after 8 weeks, till maximum response. Dose in breast cancer: One ampoule subcutaneous weekly during the course of chemotherapy. For full mode of administration refer to Viscum product monograph. CONTRAINDICATIONS: In acute inflammatory conditions or if the temperature is above 38C: treatment should be discontinued until the fever and the inflammation subside. Known hypersensitivity to Mistletoe preparations. Studies on use for infants and young children are not available. Pregnancy use should be limited to special circumstances. SIDE EFFECTS: For full information about side effects refer to Viscum Fraxini 2 product monograph.

Each ampoule of 1 ml contains: Mistletoe extract (Equivalent to 10000 ng Lectins) Pack size: 3 ampoules 1 ml of aqueous solution for injection. Precautions/drug interactions: Keep in cool dry place (8-16C) in the lower part of the refrigerator. Keep out of reach of children.
ONCOLOgy

15 mg

ONCOLOgy

Cardioton
Cardiotonic PROPERTIES AND ACTIONS: Cardioton improves myocardial contractility via inhibition of C-AMP phosphodiesterase enzymes. It also improves tissue perfusion through a vasodilator action mediated via activation of endothelial derived relaxing factors resulting in coronary vasodilatation of normal and atherosclerotic vessels with an increase of coronary blood flow. Cardioton has peripheral arteriolar vasodilator effect with a reduction in peripheral resistance and mild reduction in blood pressure. INDICATIONS: Heart failure NYHA class I and II. Ischemic heart disease. Hypertension. Senile cardiomyopathy. DOSAGE: Unless otherwise prescribed by the physician; 1-2 tablets 3 times/day. CONTRAINDICATIONS: Pregnancy, lactation and children younger than 12 years old. SIDE EFFECTS: Very rare occurrence of gastro-intestinal disturbances, headache and dizziness. PRECAUTIONS/DRUG INTERACTIONS: Cardioton has no recorded drug interactions. Cardioton is safely administered with digitalis.

Each tablet contains: Crataegus oxycantha extract 300 mg (Equivalent to 2.15 % flavonoids) Pack size: 20 tablets in 2 blisters.

CARDIOVASCULAR

CARDIOVASCULAR

Statosan
For healthy lipid profile PROPERTIES AND ACTIONS: Statosan is a natural source of at least 9 cholesterol-lowering compounds (natural statins) and is rich in Mevino linic acid, a natural lipid-lowering agent. Mevinolinic acid, unlike other statins, is activated without the need of prior hydrolysis in the liver thus reducing the strain on the liver. Statosan lowers plasma cholesterol levels by inhibiting 3-hydroxy, 3-methylgluteryl-COA (HMG-COA) reductase enzymes. This reduces cholesterol synthesis by the liver and increases the number of LDL receptors on the cell surface, thereby increasing LDL-cholesterol uptake and catabolism and decreasing its overall serum levels. Statosan is effective in mixed dyslipidemia as it reduces triglycerides and increases HDL-cholesterol. Monascus pigment and other natural metabolites of Red Yeast Rice are also free radical scavengers that prevent the oxidation of LDL cholesterol and thereby reduce the risk of coronary artery diseases. INDICATIONS: Primary hypercholesterolemia and mixed dyslipidemia. Elevated serum triglyceride level. DOSAGE: Unless otherwise prescribed by the physician; one capsule 2 times/day. CONTRAINDICATIONS: Not recommended during pregnancy or lactation. Not to be taken in case of advanced liver disease. SIDE EFFECTS: None reported within the therapeutic dose. PRECAUTIONS/DRUG INTERACTIONS: No special precautions or drug interactions reported.
Each hard gelatin capsule contains: Red Yeast Rice Powder 500 mg (Standardized to contain 10 mg/g Mevinolinic acid and related monacolins) Pack size: 30 capsules in 3 blisters.

10

CARDIOVASCULAR

CARDIOVASCULAR

11

Carmipret
Anti-spasmodic/anti-flatulent PROPERTIES AND ACTIONS: Carmipret acts by causing smooth muscle relaxation and blocking the influx of calcium into muscle cells. This improves the rhythmic contraction of the intestine and relieves spasm. Carmipret s carminative effect; relieves abdominal distension and flatulence. Carmiprets choleretic effect; improves dyspeptic symptoms as well as intestinal symptoms. Carmipret enteric coated capsules will not breakdown until it reaches the small intestine, so it doesnt cause heartburn. INDICATIONS: Functional dyspepsia. Irritable bowel syndrome. DOSAGE: One capsule 3 times daily, 15-30 minutes before meals. CONTRAINDICATIONS: In cases of biliary obstruction. SIDE EFFECTS: None reported within the therapeutic dose. PRECAUTIONS/DRUG INTERACTIONS: Carmipret and antacids should be taken with an interval around one hour to avoid premature dissolution of the capsule.

Each enteric coated capsule contains: Peppermint oil Caraway oil Pack size: 30 capsules in 3 blisters. 90 mg 50 mg

12

GASTRO-INTESTINAL

GASTRO-INTESTINAL

13

Chamopect
Anti-diarrheal PROPERTIES AND ACTIONS: Chamopect reduces duration of diarrhea. It contains Pectin which improves with its swelling ability, the passage of well formed stools, adsorbs toxins and mucosal irritating substances in the intestinal lumen and forms a protective film on the intestinal mucosa. Chamopect is used as a supportive treatment in bacterial diarrhea and improves the associated symptoms of diarrhea. Chamopect contains Chamomile extract which has spasmolytic, anti-inflammatory and ulceroprotective effects. Chamopect has high acceptance and high tolerability. INDICATIONS: Gastroenteritis especially in infants and children. Supportive treatment in case of bacterial diarrhea. CONTRAINDICATIONS: None reported. SIDE EFFECTS: None reported within the therapeutic dose. PRECAUTIONS/DRUG INTERACTIONS: No specific precautions or drug interactions.
DOSAGE (Unless otherwise prescribed by the physician) the recommended dose is:

Age
Adults & School Children Young Children Infants

Starting Dose
2 tablespoons 2 teaspoons (10 ml) 1 teaspoon (5 ml)

Maintenance
1 tablespoon/hr (min. 4-6 times/day) 1 teaspoon(5ml)/hr (min. 4-6 times/day) teaspoon (2.5 ml)/hr (min. 4-6 times/day)

After Resolution
1 tablespoon (3 times/day) 1 teaspoon (5 ml) (3 times/day) teaspoon (2.5 ml) (3 times/day) Each 200 ml contains: Pectin Chamomile extract Pack Size: Bottle contains 200 ml. 6.4 g 5g

14

GASTRO-INTESTINAL

GASTRO-INTESTINAL

15

Heparex
Dyspepsia with hepato-biliary disorders PROPERTIES AND ACTIONS: Heparex has choleretic and cholekinetic effects, which stimulate the digestive process and improve fatty dyspepsia. Higher bile secretion increases the yield of bicarbonate in the duodenum that neutralizes excessive acidity, and improves dyspepsia. It also has anticholestatic activity that enhances biliary excretion and reduces symptoms of irritable bowel syndrome. Heparex has an antioxidative effect. Its active ingredients (luteolin, cynarin, chlorogenic acid and caffeic acid) protect the liver against toxins and reduce the free radicals' induced hepatocyte killing effect. Its caffeoylquinoic acid acts as a cell membrane stabilizer. INDICATIONS: Dyspepsia, indigestion and irritable bowel syndrome (distension, flatulence, fat indigestion), etc.. Cholecystitis (especially calcular cholecystitis, where it helps in stone dissolution). Supportive therapy in chronic liver diseases (liver cirrhosis, fatty liver, etc.). DOSAGE: Unless otherwise prescribed by the physician; 1-2 capsules 3 times/day half an hour before meals. CONTRAINDICATIONS: Biliary obstruction, allergy to cynara or any of its components. SIDE EFFECTS: None reported within the therapeutic dose. PRECAUTIONS/DRUG INTERACTIONS: No special precautions or drug interactions known.

Each hard gelatin capsule contains: Cynara scolymus dried extract 320 mg (Equivalent to caffeoylquinoic acid 1.6 mg) Pack size: 20 capsules in 2 blisters.

16

GASTRO-INTESTINAL

GASTRO-INTESTINAL

17

Fiminosan
Menopausal symptoms relief PROPERTIES AND ACTIONS: Fiminosan is a hormone free alternative to estrogen replacement therapy to treat hot flushes, sweating, headache, nervousness, palpitation, sleep disturbances, and other symptoms of ovarian insufficiency that are especially common in perimenopausal and menopausal women. Fiminosan exerts selective estrogen receptor modulatory activity on the hypothalamus and the anterior pituitary gland and thereby influences ovarian function and the neurotransmitters levels hence has an antidepressant effect and improves the psychic, vegetative and partially somatic disturbances that result from the changes to the hormonal levels during menopause. DOSAGE: Unless otherwise prescribed by the physician; 1 tablet 2 times/day. No immediate effect of Fiminosan is expected, but after approximately 4-6 weeks of treatment. CONTRAINDICATIONS: There are no restrictions on the use of Fiminosan and it has an excellent tolerance. None reported. SIDE EFFECTS: Fiminosan has no carcinogenic effects. Occasionally slight GIT discomfort may occur. PRECAUTIONS/DRUG INTERACTIONS: INDICATIONS: Climacteric complaints. Post operative manifestations of ovarian insufficiency e.g. following bilateral oophorectomy. Support for hormonal therapy. No specific precautions or drug interactions known.

Each tablet contains: Cimicifuga racemosa dry extract 20 mg (Standardized to contain minimum 2.5% triterpeneglycosides.) Pack size: 30 tablets in 3 blisters.

18

GYNAECOLOGY

GYNAECOLOGY

19

Femicur
Pre-menstrual symptoms relief PROPERTIES AND ACTIONS: Femicur has an inhibitory effect on prolactin release through a dopaminergic principle of action mediated by D2 receptors (binding inhibition). Lowering the prolactin level cancels the disturbed secretion of gonadotrophins and normalizes the physiological estrogen/progesterone ratio which in turn abolishes the proliferative effect of prolactin on the mammary gland. Additional action in relieving pre-menstrual syndrome may be mediated by opioid receptors binding inhibition. INDICATIONS: PRECAUTIONS/DRUG INTERACTIONS: Pre-menstrual syndrome. Mastalgia due to hormonal disturbances as hyper-prolactinemia. Menstrual disorders as menorrhagia, metrorrhagia, polymenorrhea and oligomenorrhea. Femicur capsules are not suited for the treatment of malignant diseases of the breast. DOSAGE: One capsule in the morning, the treatment should be continued at least for three months without interruption. CONTRAINDICATIONS: None reported. SIDE EFFECTS: In rare cases, itching, urticarial rashes (exanthemas), headache, dizziness, and dry mouth may occur. In very rare cases confusion and agitation have been reported.

Each capsule contains: Vitex agnus-castus extract 20 mg (Standardized to contain not less than 0.6% aucubin) Pack size: 30 capsules in 3 blisters. To be launched in 2011.

20

GYNAECOLOGY

GYNAECOLOGY

21

Femivit
For females health & wellbeing PROPERTIES AND ACTIONS: Femivit contains Borage and Evening Primrose oils which are rich sources of the polyunsaturated fatty acid -linolenic acid (GLA). GLA is an important omega 6 nutrient which cannot be manufactured in the body but must be provided in the food. Omega 6 is an essential component of all membranes, conferring properties of fluidity and flexibility. By modulating membrane properties, omega 6 also modulates the behaviors of membrane associated proteins such as receptors, enzymes, ion channels and messenger systems. In addition to this structural role, with its functional consequences, omega 6 also acts as the precursor of a whole variety of short-term mediators, which regulate many aspects of cellular function. These mediators include several different prostaglandins, leukotrienes and thromboxanes, together with various other types of oxygenated essential fatty acids derivatives. One of these mediators is prostacyclin, formed from arachidonic acid (AA). Femivit provides the polyunsaturated fatty acid GLA in the form most effectively absorbed and utilized by the body. GLA helps women to maintain hormonal harmony, healthy skin; and also helps joint mobility and general health and wellbeing. INDICATIONS: Maintenance of healthy skin and general wellbeing in females. DOSAGE: 1-3 capsules three times daily. CONTRAINDICATIONS: Not used during pregnancy and lactation. SIDE EFFECTS: Mild gastrointestinal discomfort may occur. PRECAUTIONS/DRUG INTERACTIONS: No specific precautions or drug interactions were reported.
Each soft gelatin capsule contains: Borage oil 273 mg (Standardized to contain Gamma-linolenic acid 17-27% - Linoleic acid 30-41%) Evening primrose oil 136.5 mg (Standardized to contain Gamma-linolenic acid 7-14% - Linoleic acid 65-85%) Pack size: 20 capsules in 2 blisters. * To be launched in 2011.

22

GYNAECOLOGY

GYNAECOLOGY

23

Heparsan
Liver support/hepato-biliary disorders PROPERTIES AND ACTIONS: Heparsan has an antioxidant activity as it contains curcumin which protects the liver against exogenous toxins. Curcumin also proved, in studies, to suppress hepatic stellate cells and decrease fibrosis which may delay fibrosis in chronic liver diseases. Heparsan has an anti-inflammatory activity due to isoquinoline alkaloids in chelidonium; its curcumin content inhibits prostaglandins while the volatile oils suppress acute edema by inhibition of hyaluronidase enzyme. Heparsan has a choleretic effect, which stimulates production of bile and pancreatic digestive enzymes that improves dyspepsia. It also has a cholecystokinetic effect. The alkaloids in Chelidonium and curcumin in Curcuma relieve the spasm and stimulate the under-active gallbladder, that help in biliary dyskinesia, cholecystitis, and gallstones. INDICATIONS: Liver support in chronic liver diseases. Biliary dysfunction (gallstones, cholecys titis, biliary dyskinesia). Dyspepsia and indigestion (distention, flatulence, fat indigestion...). DOSAGE: One capsule 3 times daily. CONTRAINDICATIONS: During first trimester of pregnancy. Biliary obstruction. Acute hepatitis. SIDE EFFECTS: No side effects reported within the therapeutic dose. PRECAUTIONS/DRUG INTERACTIONS: No special precautions or drug interactions known.

Each soft gelatin capsule contains: Dry extract Chelidonium majus 100 mg Dry extract of Curcuma xanthorrhizae 60 mg Curcuma xanthorrhizae oil 10 mg Pack size: 30 capsules in 3 blisters.

24

HEPATO-BILIARY

HEPATO-BILIARY

25

Immulone
Non specific immune enhancer PROPERTIES AND ACTIONS: Caffeic acid derivatives (mainly chicoric acid), alkamides and polysaccharides are the main effective groups in Echinacea, the main active constituent of Immulone. Immulone contains also vitamin C which supports the integrity of mucous membranes. Immulone stimulates the immune response by enhancing phagocytosis by macrophages and activation of natural killer cells. Immulone increases cytokine production, such as interferon which helps in controlling viral infection. Immulone has mild direct antibacterial activity and direct anti-inflammatory activity. Immulone has anti-hyaluronidase enzyme activity which prevents spreading of infection and accelerates recovery. Immulone increases phagocytosis of candida by 45% and decreases the rate of recurrence of fungal infections. Through these actions, Immulone enhances the resistance to viral, bacterial and fungal infections in healthy subjects and shortens the duration of illness and helps in rapid recovery.
Age Dosage Time Children (5-9 yrs)
1-2 lozenges 1 time/day

INDICATIONS: Prevention and treatment of common cold and influenza. Prophylactic therapy in cases of increased susceptibility to infections. Inflammatory skin diseases. Recurrent vaginal candidiasis. CONTRAINDICATIONS: Hypersensitivity to the active substance. In accordance with general principles, not to be used in patients with progressive systemic diseases such as tuberculosis, collagenoses, multiple sclerosis, HIV infection and autoimmune diseases. SIDE EFFECTS: In rare cases hypersensitivity reactions, e.g. skin reactions, can occur.
Each lozenge contains: Echinacea purpurea extract Vitamin C Precautions/drug interactions: The duration of continuous treatment should not exceed 8 weeks. No reported drug interactions. Pack size: 20 lozenges in 2 blisters.
IMMUNOLOGY

150 mg 50 mg

DOSAGE (Unless otherwise prescribed by the physician) the recommended dose is: Adolescents (10-14 yrs)
1 lozenge 3 times/day

Adults & Adolescents (> 14 yrs)

26

IMMUNOLOGY

27

Mulone
Non specific immune enhancer PROPERTIES AND ACTIONS: Caffeic acid derivatives (mainly chicoric acid), alkamides and polysaccharides are the main active constituent in Echinacea, the main of Mulone extract. Mulone stimulates the immune response by enhancing phagocytosis by macrophages and activation of natural killer cells. Mulone increases cytokine production, such as interferon which helps in controlling viral infection. Mulone has mild direct antibacterial activity and direct anti-inflammatory activity. Mulone has anti-hyaluronidase enzyme activity which prevents spreading of infection and accelerates recovery. Mulone increases phagocytosis of candida by 45% and decreases the rate of recurrence of fungal infections. Through these actions; Mulone enhances the resistance to viral, bacterial and fungal infections in healthy subjects and shortens the duration of illness and helps in rapid recovery. INDICATIONS: Prevention and treatment of common cold and influenza. Prophylactic therapy in cases of increased susceptibility to infections. Inflammatory skin diseases. Recurrent vaginal candidiasis. CONTRAINDICATIONS: Hypersensitivity to the active substance. In accordance with general principles, not to be used in patients with progressive systemic diseases such as tuberculosis, collagenoses, multiple sclerosis, HIV infection and autoimmune diseases. SIDE EFFECTS: In rare cases hypersensitivity reactions, e.g. skin reactions, can occur.

Each 100 ml contains: Echinacea purpurea dry extract 3.75 g (Standardized to contain 3% chicoric acid) PRECAUTIONS/DRUG INTERACTIONS: Refrigerate after opening & use within 14 days. The duration of continuous treatment should not exceed 8 weeks. No reported drug interactions. Pack size:

DOSAGE (Unless otherwise prescribed by the physician) the recommended dose is: Age Dosage Time Children (5-9 yrs)
2.5 ml ( a teaspoonful) 1-2 times/day

Adolescents (10-14 yrs)

Adults & Adolescents (> 14 yrs)

Bottle of 30 ml drops. Bottle of 60 ml syrup.

28

IMMUNOLOGY

29

Viscum Fraxini 4
Immunomodulator PROPERTIES AND ACTIONS: Viscum Fraxini 4, Mistletoe extract, stimulates the T-cell and B-cell components of the immune system, which leads to the expression and release of cytokines and proliferation and activation of immuno-competent cells. Viscum Fraxini 4 is associated with improvement of patients' quality of life parameters, as it stimulates the secretion of endogenous -endorphins with consequent control of pain, improvement of appetite and sleep quality. Treatment with Viscum Fraxini 4 is associated with increased level of endogenous interferon that protects cells from viral infection. INDICATIONS: Viral infections e.g. hepatitis virus, papilloma virus. Immune enhancer in cases of immune deficiency e.g. post chemotherapy, convalescence, etc.. DOSAGE: Unless otherwise prescribed by the physician; 1 ampoule subcutaneous Viscum Fraxini 4, once/week. For full mode of administration refer to Viscum Fraxini 4 product monograph. CONTRAINDICATIONS: In acute inflammatory conditions or if the temperature is above 38C, treatment should be discontinued until the fever and the inflammation subside. Known hypersensitivity to Mistletoe preparations. Studies on use for infants and young children are not available. In pregnancy the therapy should be limited to special circumstances. SIDE EFFECTS: For full information about side effects refer to Viscum Fraxini 4 product monograph. PRECAUTIONS/DRUG INTERACTIONS: Keep in cool dry place (8-16C) on the refrigerators shelf. Keep out of reach of children.
Each ampoule of 1 ml contains: Mistletoe extract (Equivalent to 100 ng Lectins) Pack size: 3 ampoules each 1 ml of aqueous solution for injection. 0.15 mg

30

IMMUNOLOGY

IMMUNOLOGY

31

Kingosan
Improves cerebrovascular circulation PROPERTIES AND ACTIONS: Kingosan improves the microcirculation and promotes the revascularization of ischemic tissues. Kingosan diminishes platelet activity and inactivates the platelet activating factor (PAF) through competitive interaction with the PAF membrane receptors. The antioxidant activity of Kingosan is mediated by the Ginkgo and Ginger content and greatly reduces oxidative metabolism in cerebral neurons by scavenging free radicals. Both the free radicals scavenging activity and the PAF antagonism protect and improve cerebral blood flow. Kingosan acts as a memory-enhancer because it modifies the concentration of neurotransmitters and anti-motion sickness effect through central and peripheral actions exerted by its Ginger content. INDICATIONS: Cerebrovascular insufficiency. Vertigo and motion sickness. Memory disorders and dementia associated with aging. DOSAGE: Unless otherwise prescribed by the physician; 1-2 capsules 1-2 times/day. CONTRAINDICATIONS: None reported. SIDE EFFECTS: None reported within the therapeutic dose. At higher doses mild GIT discomfort may occur. PRECAUTIONS/DRUG INTERACTIONS: Caution in patients on anticoagulants or anti-platelet medication.

Each hard gelatin capsule contains: Ginger extract 100 mg (Standardized to contain not less than 5% gingeroles) Ginkgo extract 60 mg (Standardized to contain 24.5% ginko flavonglycosides) Pack size: 30 capsules in 3 blisters. To be launched in 2012.

32

NEUROPSYCHIATRY

NEUROPSYCHIATRY

33

Neuropatex
Against neuropathies PROPERTIES AND ACTIONS: Alpha-lipoic acid is a very unstable molecule that has tendency to polymerize on exposure to heat, light, and moisture, turning into a sticky and ineffective product. Neuropatex through its unique Self Emulsifying Drug Delivery System (SEDDS) ensures maximum stability, bioavailability and maximum effectiveness of alpha lipoic acid. Neuropatex prevents the oxidative damage and reduces oxidative stress which is the main contributing factor in diabetic neuropathy through its potent antioxidant effect in both oxidized and reduced forms. Neuropatex regenerates endogenous antioxidants activity of both vitamin C and E and enhances intracellular levels of glutathione and coenzyme Q-10 which are impaired and consumed in diabetic patients. Neuropatex improves endoneurial perfusion through improvement of nitric oxide (NO) mediated vasodilatation, thus enhances the microcirculation and helps in peripheral nerve regeneration. Neuropatex improves microcirculation so decreases the risk of vascular complications especially retinopathy, nephropathy and cardiovascular complications and also has proven efficacy in treatment of different forms of autonomic neuropathy. Neuropatex is effective in different diseases associated with lowered antioxidant status and/or increased levels of oxidative stress as in neurodegenerative disorders. INDICATIONS: Diabetic neuropathy. Neuritis, polyneuritis and optic neuritis. Prophylaxis against long term vascular and neurological complications in diabetic patients. Helps in primary and secondary prevention of stroke in diabetic patients. DOSAGE: One capsule daily preferred on an empty stomach. CONTRAINDICATIONS: Hypersensitivity to alpha-lipoic acid. SIDE EFFECTS: Mild GIT upset with high dose have been reported in some cases. Precautions/drug interations:
There are no adequate studies for its use in pregnancy and lactation. Each soft gelatin capsule contains: Alpha-lipoic acid Pack size: 20 capsules in 2 blisters. 600 mg

34

NEUROPSYCHIATRY

NEUROPSYCHIATRY

35

Safamood
Psychosomatic disorders PROPERTIES AND ACTIONS: Safamood regulates motility, sensitivity, and secretion of fluids of GIT. Safamood inhibits synaptic reuptake of serotonin and to a lesser extent norepinephrine, resulting in increased levels of these neurotransmitters in the synapse and modulates the level of cytokines so it has an antidepressant effect and reduces the psychosomatic symptoms. Safamood has a potential analgesic effect through activation of endogenous paininhibitory system in the brain. Safamood exerts a mild anxiolytic action through the inhibition of Gamma Amino Butyric Acid (GABA) reuptake pump. Safamood is well tolerated and causes no psychological or physical dependence, muscle relaxation, or cognitive impairment. INDICATIONS: Psychosomatic symptoms e.g. psychogenic GIT disturbances, irritable bowel syndrome. DOSAGE: Unless otherwise prescribed by the physician; one tablet 2-3 times/daily. CONTRAINDICATIONS: Pregnancy and lactation. SIDE EFFECTS: None reported within the therapeutic dose. PRECAUTIONS/DRUG INTERACTIONS: Plasma level of Warfarin, Digoxin, Theophylline, and Contraceptive pills may be reduced with Safamood as it has enzyme inducing effects accelerating their metabolism. Concomitant use with Selective Serotonin Reuptake Inhibitors (SSRIs) may cause serotonin syndrome.

Each tablet contains: Hypericum perforatum dry extract 250 mg (Standardized to contain minimum 0.12% dianthrones calculated as Hypericine) Vitamin C 50 mg Pack size: 20 tablets in 2 blisters.

36

NEUROPSYCHIATRY6

NEUROPSYCHIATRY

37

Safamood Forte
Anti-depressant PROPERTIES AND ACTIONS: Safamood Forte is an active antidepressant, because it inhibits synaptic reuptake of serotonin and to a lesser extent norepinephrine, resulting in increased levels in the synaptic gap. Safamood Forte suppresses interleukin6 (IL6), and thereby promotes the deactivation of the hyperactive hypothalamicpituitary-adrenal axis (HPA). Safamood Forte indirectly inhibits the secretion of corticosteroids. Safamood Forte exerts a mild anxiolytic action through the inhibition of the Gamma Amino Butyric Acid (GABA) reuptake pumps. Safamood Forte is well tolerated and causes no physical dependence, muscle relaxation or cognitive impairment. There has never been a report of toxicity in humans. INDICATIONS: Mild and moderate depression. Obsessive compulsive disorders (OCD). Psychosomatic disorders. CONTRAINDICATIONS: Not to be used during pregnancy and lactation. SIDE EFFECTS: GIT discomforts and headaches are slight and rare. Light sensitivity may occur. PRECAUTIONS/DRUG INTERACTIONS: Plasma levels of Cyclosporine, Digoxin and Theophylline may be reduced and oral Contraceptive pills are less effective because their metabolism is accelerated. Concomitant administration with MonoAmine Oxidase Inhibitors (MAOIs) and Selective Serotonin Reuptake Inhibitors (SSRIs) may increase their side effects.
Each film coated tablet contains: Hypericum perforatum extract 600 mg (Standardized to contain minimum 0.12% hypericin)Pack Pack size: 20 tablets in 2 blisters.
NEUROPSYCHIATRY

DOSAGE (Unless otherwise prescribed by the physician) the recommended dose is:

Depression and OCD

Psychosomatic disorders
1 tablet/day

38

NEUROPSYCHIATRY

39

Sedaneurin
Anxiolytic, sedative PROPERTIES AND ACTIONS: Sedaneurin is an anxiolytic drug with a dose-dependent sedative effect. It shows a potentiating effect in enhancement of GABA (Gamma Amino Butyric Acid) pathway, which is the main inhibitory neurotransmitter in the central nervous system, thus acts as sedative and sleep promoting agent. Sedaneurin has an antidepressant effect due to inhibition of serotonin and to lesser extent the norepinephrine reuptake pump. Sedaneurin restores normal sleep pattern through the increase of melatonin that plays a crucial role in the etiology of affective disorders and sleep. Moreover Hypericum increases its nocturnal production. Sedaneurin doesnt cause substance dependence, habituation or hangover effect. INDICATIONS: Mild and moderate nervous tension and stress. Mixed anxiety and depressive disorders. Occasional, transient or chronic insomnia. Psychosomatic disorders. CONTRAINDICATIONS: Pregnancy and Lactation. SIDE EFFECTS: None reported within the therapeutic dose. With overdose mild symptoms such as blurred vision, headache, restlessness, GIT symptoms were noted. PRECAUTIONS/DRUG INTERACTIONS: If used with benzodiazepines the dose should be reduced.

Each tablet contains: Valeriana officinalis dry extract 160 mg (Standardized to contain minimum 0.3% sesquiterpinic acids expressed as valerenic acid) Hypericum perforatum dry extract 100 mg (Standardized to contain minimum 0.12% dianthrones calculated as Hypericine) Pack size: 20 tablets in 2 blisters.

DOSAGE (Unless otherwise prescribed by the physician) the recommended dose is:

Anxiolytic
Dosage 1-2 tablets/day

Insomnia
2 tablets 1 hour before bedtime

40

NEUROPSYCHIATRY

NEUROPSYCHIATRY

41

Rosinol
Bronchodilator, expectorant PROPERTIES AND ACTIONS: Rosinol contains up to 90% Anethole. Anethole is absorbed by the stomach, and mostly excreted via the lungs. Rosinol activates secretolytic and secretomotor activities of respiratory mucosa and improves ciliary movement. Rosinol contains the most effective dose of Anise oil needed to liquefy the viscid bronchial secretions and enhances the mucociliary expectoration. Rosinol has antiseptic and spasmolytic effects, which help to relieve symptoms of respiratory catarrh and bronchitis. INDICATIONS: Acute productive cough. Chronic bronchitis and tracheitis. Bronchial asthma and spasmodic cough. DOSAGE: Unless otherwise prescribed by the physician; 1-2 capsules 3 times/day. CONTRAINDICATIONS: First and second trimesters of pregnancy. SIDE EFFECTS: None reported within the therapeutic dose. PRECAUTIONS/DRUG INTERACTIONS: No special precautions or drug interactions.

Each soft gelatin capsule contains: Anise oil Pack size: 20 capsules in 2 blisters. 100 mg

42

RESPIRATORY

RESPIRATORY

43

Thymotal
Mucolytic, expectorant PROPERTIES AND ACTIONS: Thymotal increases hydration of the respiratory system by increasing water content of mucous to liquefy thick mucous, and stimulates the mucociliary apparatus. Thymol and Carvacrol in Thymotal have a broad spectrum antibacterial activity by enhancing bacterial membrane perforation. Flavonoids in Thymotal inhibit calcium influx of the smooth muscles leading to smooth muscle relaxation. INDICATIONS: Acute and chronic bronchitis. Upper respiratory tract infections. Asthmatic bronchitis. CONTRAINDICATIONS: None reported. SIDE EFFECTS: None reported within the therapeutic dose. PRECAUTIONS/DRUG INTERACTIONS: No special precautions or drug interactions.
DOSAGE (Unless otherwise prescribed by the physician) the recommended dose is: Age Dosage Time

Children 2-12 years

12-18 years
2.5 ml 3 times/day

Adults
5 ml 3 times/day Each 1 ml (15 drops) contains: Thyme fluid extract 0.33 g (Standardized to contain not less than 0.03% total phenolic cempounds calculated as thymol) Pack size: Bottle of 100 ml syrup. Bottle of 30 ml drops.

44

RESPIRATORY

RESPIRATORY

45

Thymotal Plus
Mucolytic, expectorant PROPERTIES AND ACTIONS: Thymol and flavonoids in Thymotal Plus have secretolytic activity as they increase serous inter-ciliary fluid production to liquefy mucous. Thymotal Plus has an antibacterial effect against gram-positive and gramnegative bacteria and fungi, also an antiviral activity through enhancing endogenous interferon gamma production. Flavonoids content of Thymotal Plus has anti-spasmodic activity leading to relaxation of smooth muscles of the airways. Thymus vulgaris has anti-oxidant properties. Thymotal Plus is alcohol free. INDICATIONS: Acute and chronic bronchitis. Upper respiratory tract infections. Asthmatic bronchitis. CONTRAINDICATIONS: Not recommended during pregnancy. SIDE EFFECTS: None reported within the therapeutic dose. PRECAUTIONS/DRUG INTERACTIONS: No special precautions or drug interactions.
DOSAGE (Unless otherwise prescribed by the physician) the recommended dose is: Age Dosage Time

Children
2.5 ml syrup 3 times/day

Adults
5 ml syrup 3 times/day Each 100 ml contains: Thyme (Thymus vulgaris fluid extract) 40 g (Standardized to contain minimum 10% Hederacoside C) Ivy (Hedera Helix extract) 0.7 g (Standardized to contain minimum 10%) Pack size: Bottle of 100 ml syrup. To be launched in 2012.

46

RESPIRATORY

RESPIRATORY

47

Boswelia
Anti-inflammatory (anti-leukotriene) PROPERTIES AND ACTIONS: Acetyl 11-Keto--boswellic acid (AKBA), a natural pentacyclic triterpene, is the major constituent of Boswellia serrata resin. Boswelia is the first selective, direct, non-competitive, and non-redox type inhibitor of 5-Lipoxygenase, which is the key enzyme for Leukotriene biosynthesis. Boswelia reduces the inflammatory process in diseases associated with increased Leukotriene production. Boswelia reduces asthmatic attacks through restoration of the altered cellular activity, which usually accompanies the inflammatory process and contributes to the signs and symptoms of asthma. Boswelia induces 80% remission in patients with ulcerative colitis grade II and III. Boswelia reduces symptoms of rheumatoid arthritis including reduction of swelling, pain and morning stiffness. INDICATIONS: Chronic inflammatory diseases: osteoarthritis, ulcerative colitis, rheumatoid arthritis and bronchial asthma. DOSAGE: 1-2 capsules 3 times/day. CONTRAINDICATIONS: Pregnancy and lactation. SIDE EFFECTS: None reported, within the therapeutic dose. PRECAUTIONS/DRUG INTERACTIONS: No specific precautions or drug interactions known.

Each capsule contains: Boswellia serrata extract 500 mg (Standardized to contain minimum 42% total organic acids calculated as -Boswellic acid) Pack size: 20 capsules in 2 blisters. To be launched in 2012.

48

RHEUMATOLOGY/ORTHOPEDIC

RHEUMATOLOGY/ORTHOPEDIC

49

Herpago
Anti-inflammatory PROPERTIES AND ACTIONS: Herpago has anti-inflammatory, mild analgesic and anti-exudative effects. Herpago reduces swelling, relieves pain and improves mobility of the joints. Herpago; iridoid glycosides and harpagoside contents are cyclooxygenase (COX) inhibitors mainly COX2 and to lesser extent COX1, reducing synthesis of the prostaglandins that play a major role in the causation of inflammation and pain. Herpago reduces the synthesis of TNF alpha and the release of cartilage metabolism regulating cytokine, interleukin-6, thus inhibits the acute phase reaction and production of pyrogens. The cytokines interleukin-1 and leukotreine B4 are not affected. Unlike NSAIDs, Herpago does not cause gastritis, it has a choleretic effect resulting in increased production of bile, and thereby it increases the yield of bicarbonate in the duodenum and neutralizes excessive acidity. INDICATIONS: Low back pain and sciatica. Inflammatory and degenerative forms of rheumatic pain: osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Sport injuries and sprains, musculoskeletal pains and tendenitis. DOSAGE: Unless otherwise prescribed by the physician: 1-2 capsules 3 times/day for 6-12 weeks. CONTRAINDICATIONS: During first trimester of pregnancy. SIDE EFFECTS: None reported within the therapeutic dose. PRECAUTIONS/DRUG INTERACTIONS: Herpago may affect the action of Warfarin, patients should be monitored regularly for adjustment of Warfarin dose.

Each hard gelatin capsule contains: Harpagophytum procumbens dried extract 400 mg (Standardized to contain minimum > 0.5% total Iridoid calculated as Harpagosid) Pack size: 20 capsules in 2 blisters.

50

RHEUMATOLOGY/ORTHOPEDIC

RHEUMATOLOGY/ORTHOPEDIC

51

Spondex
Chondro-protective PROPERTIES AND ACTIONS: Spondex restores the normal cartilage structure by stimulating the synthesis of proteoglycans and collagen as well as inhibiting collagenase type II. Due to its action as anti-oxidant, Spondex prevents the damage caused by free radicals associated with specific disorders and life style patterns, including aging and rheumatic diseases. Spondex reduces the damaging effect of NSAIDs on the gastro-duodenal mucosa as it normalizes the phospholipid content of the endothelial cells. Spondex is the most effective lipid soluble, chain breaking antioxidant that protects the cell membrane from peroxidative damage. Spondex combats free-radical-mediated pathology that develops over time in several degenerative diseases, as well as inflammatory processes. Spondex aids the healing process of mechanical tissue injuries and those due to cell rupture. Natural D-alpha tocopherol is 40% more effective than the synthetic one, as it binds with higher affinity to the active sites on the cell membrane. INDICATIONS: Osteoarthritis. Rheumatoid arthritis. Ankylosing spondylitis. Traumatic injuries and muscle strains. DOSAGE: Unless otherwise prescribed by the physician; 1-2 capsules 3 times/day after meals, for 6-12 weeks. CONTRAINDICATIONS: Bleeding tendency in advanced liver diseases. SIDE EFFECTS: None reported within the therapeutic dose. PRECAUTIONS/DRUG INTERACTIONS: For patients on anticoagulant therapy, follow up of coagulation profile is advised.

Each soft gelatin capsule contains: D-alpha tocopherol concentrate Pack size: 2, 3 or 5 blisters, 6 capsules/blister. 400 mg

52

RHEUMATOLOGY/ORTHOPEDIC

RHEUMATOLOGY/ORTHOPEDIC

53

Cystinol
For urolithiasis (and anti-inflammatory) PROPERTIES AND ACTIONS: Cystinol promotes the excretion of water more than electrolytes by increasing renal blood flow. This aquaretic effect facilitates the washout of bacteria from the urinary tract, prevents crystal formation and hence kidney stones. Cystinol inhibits the synthesis of prostaglandinic acid metabolites and therefore has an anti-inflammatory effect. The flavonoid content of Cystinol also has anti-inflammatory, anti-microbial and immunomodulatory properties. This anti-inflammatory effect supports urinary tract healing after passage of stones. Cystinol has an analgesic effect because it binds pain receptors. The mild spasmolytic effect of Cystinol relaxes contracted smooth muscles and thus relieves the pain associated with inflammation and stones. The saponin content of Cystinol provides anti-infective properties through non specific immunostimulation while the ester-saponin exerts an anti-fungal effect against candida albicans and other candida species. INDICATIONS: Prophylaxis and treatment of crystalluria, and recurrent stone formation. Inflammatory diseases of the urinary tract. Adjuvant therapy to anti-microbials in urinary tract infection. Before and after operations and any invasive procedure to the urinary tract. DOSAGE: Unless otherwise prescribed by the physician; 1 capsule 3-4 times/day (with a lot of fluids). CONTRAINDICATIONS: The safe use during pregnancy and lactation is not sufficiently well documented. SIDE EFFECTS: None reported within the therapeutic dose.
Each hard gelatin capsule contains:

PRECAUTIONS/DRUG INTERACTIONS: No special precautions or drug interactions known.

Solidago virgaurea extract 425 mg (Standardized to contain not less than 1.5% total flavonoids calculated as Rutin) Pack size: 20 capsules in 2 blisters.

54

GENITO-URINARY

GENITO-URINARY

55

Prostasan
In benign prostatic hyperplasia PROPERTIES AND ACTIONS: Prostasan relieves most symptoms of prostatic enlargement. Increases the peak urinary flow rate, decreases residual urinary volume, decreases daytime and nocturnal urinary frequency and relieves painful micturation. Saw palmetto extract present in Prostasan exerts potent inhibitory actions on adrenoceptors and blocks calcium channels, thereby causing the spasmolytic effects and hence relieving the dynamic obstruction present in cases of prostatic enlargement. It has also anti-androgenic effect since it inhibits binding of DHT(dihydrotestosterone) to androgen receptors in prostatic cells, reduces 5 alpha reductase enzyme activity and has potent anti-estrogenic properties. The Nettle extract content of Prostasan has anti-inflammatory and anti-edematous effects because it inhibits the arachidonic acid cascade. Through this inhibition, Prostasan improves the congestion and non-infectious prostatitis commonly associated with prostatic hyperplasia. INDICATIONS: Benign prostatic hyperplasia. Prostatic enlargement accompanied by symptoms of dysuria, frequency of urination, nocturia, and incomplete bladder emptying. Adjuvant therapy in cases of acute and chronic prostatitis. DOSAGE: Unless otherwise prescribed by the physician: 1 capsule 2 times/day with meals. The treatment must be maintained for at least 1 month. CONTRAINDICATIONS: None reported. SIDE EFFECTS: Mild GIT discomfort resolves when taken with meals. PRECAUTIONS/DRUG INTERACTIONS: No specific precautions or drug interactions known.
Each soft gelatin capsule contains: Saw palmetto extract Nettle root extract Pack size: 20 capsules in 2 blisters. 60 capsules in 6 blisters. * To be launched in 2011 160 mg 120 mg

56

GENITO-URINARY

GENITO-URINARY

57

Bio-Mag
Magnesium aspartate PROPERTIES AND ACTIONS: Bio-Mag plays an important role in the regulation of vascular tone and decreases the vascular resistance. Since magnesium serves as a co-factor in the sodium-potassium pump, it prevents accumulation of sodium and calcium inside the cell, which is the cause of increased peripheral resistance and vasospasm. Bio-Mag reduces muscles excitability and cramps through reduction of neurotransmitters (catecholamines) release. Also it relaxes irritable uterine muscles by stimulating 2-adrenergic receptors and cyclic AMP production. Bio-Mags natural amino acid aspartate is the carrier molecule for the transport of magnesium in cells. In addition aspartate is involved in DNA synthesis and in carbohydrate and protein metabolism. Aspartic acid is a major excitatory transmitter in the brain. INDICATIONS: Magnesium deficiency diseases. Prevention and treatment of stress related diseases (Hypertension, Diabetes). Prevention and treatment of cardiac arrhythmia and coronary spasm. Muscle cramps, GIT cramps and migraine. Spasm in pregnancy, pre-eclampsia and dysmenorrhea. For patients with or at risk for magnesium deficiency (eating processed food, malabsorption, pancreatitis, renal dysfunction, after the use of diuretics and alcoholism). Non insulin dependent diabetes mellitus. DOSAGE: Unless otherwise prescribed by the physician: 2-3 tablets/day. CONTRAINDICATIONS: Patients with renal impairment without the advice and direct supervision of the physician. SIDE EFFECTS: None reported within the therapeutic dose. PRECAUTIONS/DRUG INTERACTIONS: Diuretics, Aminoglycosides, Immunosuppressants and Cytostatics induce an increase in renal magnesium loss. Indomethacin promotes the absorption of magnesium. It is so recommended to take magnesium and the above medications separately.
Each chewable tablet contains: Magnesium hydrogen aspartate 1803 mg (Equivalent to 121.5 mg elemental magnesium) Pack size: 20 chewable tablets in 2 blisters.

58

MINERALS

MINERALS

59

BioZinc
Zinc aspartate PROPERTIES AND ACTIONS: BioZinc is a vital constituent of metalloenzymes like cytochrome oxidase, RNA polymerase, carbonic anhydrase and carboxypeptidase. BioZinc enhances the percentage of CD4 lymphocytes and improves cell mediated immunity, hence decreases the incidence of diarrhea and respiratory tract infections, especially in elderly and diabetic patients. BioZinc can inhibit 5-alpha reductase (type I) which is required to produce dihydrotestosterone a potent hormone that is responsible for male-pattern hair loss. BioZinc blocks the formation of dihydrotestosterone within the scalp reducing its miniaturizing effects on the hair follicle, decreasing the injury it causes to the hair follicle and also the extent of the immune response targeted to the hair follicle. BioZinc is necessary for prepubertal growth, sexual maturation, semen quality and hence male fertility, and is essential for proper fetal growth. BioZinc is essential for normal epithelization of the skin and is required for hair and nail growth. BioZinc contains aspartic acid that acts as a carrier for zinc and thereby optimizes the effective intestinal absorption, and utilization of zinc. INDICATIONS: Zinc deficiency 1ry and 2ry Pregnancy and lactation Delayed wound healing Sexual dysfunction Dermatitis and acne Growth retardation in children Alopecia areata and hair loss Immune deficiency Reduced taste and smell sensation As adjuvant treatment in diabetes mellitus DOSAGE: Unless otherwise prescribed by the physician; 1 hour before meal, 1-2 tablets/ day (adult), 1 tablet/day (children). CONTRAINDICATIONS: Severe renal parenchymal damage. SIDE EFFECTS: Temporarily, a metallic taste, headache, nausea and diarrhea could occur, when overdosing. PRECAUTIONS/DRUG INTERACTIONS: No specific precautions or drug interactions reported.

Each film coated tablet contains: Zinc DL-hydrogen aspartate 50 mg (equivalent to 9.75 mg elemental zinc) Pack size: 30 tablets in 3 blisters.

60

MINERALS

MINERALS

61

Ritchkal
Calcium supplement PROPERTIES AND ACTIONS: Ritchkal is 100% natural calcium and contains a range of other minerals, such as phosphorus and magnesium. Ritchkal contains Ca:P in a ratio of 2.2:1 which contributes to efficient calcium absorption. Ritchkal may be absorbed in the absence of vitamin D. Calcium is required for normal growth, development and maintenance of the bone and teeth. Adequate calcium intake reduces the risk of several major chronic diseases including osteoporosis, hypertension, colon cancer, and possibly cardiovascular disease and obesity. Calcium is important for womens health during pregnancy, lactation and post menopause. Calcium is required for a number of basic regulatory functions including muscle contraction, blood coagulation, transmission of nerve impulses, activation of enzyme reactions, stimulation of hormone secretions and integrity of intracellular cement substances. The inhibition of bone remodeling that generally occurs in response to a high calcium intake is less marked when calcium is supplied by milk products. INDICATIONS: Calcium deficiency. During pregnancy and lactation. Prophylaxis and treatment of osteoporosis. DOSAGE: The recommended daily dose is two tablets per day. CONTRAINDICATIONS: None reported. SIDE EFFECTS: None reported within the recommended dose. PRECAUTIONS/DRUG INTERACTIONS: Taken 2 hours apart from other medications.
Each chewable tablet contains: Milk calcium 2000 mg (equivalent to 500 mg elemental calcium) Pack size: 20 chewable tablets. *To be launched in 2011

62

MINERALS

MINERALS

63

Alphabetical Product-Index B Bio-Mag 58 BioZinc 60 Boswelia 48 C Cardioton Carmipret Chamopect Cystinol F Femicur 20 Femivit 22 Fiminosan H Heparex 16 Heparsan I Immulone K Kingosan 32 M Mulone 28 26 24 Herpago 50 18 8 12 14 54 N Neuropatex P Prostasan R Ritchkal 62 Rosinol 42 S Safamood Safamood forte Sedaneurin 36 38 40 56 34

Spondex 52 Statosan 10 T Thymotal 44 Thymotal plus V Viscum Fraxini 2 Viscum Fraxini 4 6 30 46

64

ALphABEtiCAL INdEX